Genovate Biotechnology Co., Ltd.

TPEX:4130 Stock Report

Market Cap: NT$2.5b

Genovate Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4130?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders373,1260.331%
Institutions1,177,8291.05%
Private Companies1,985,0041.76%
VC/PE Firms30,098,43926.7%
General Public79,022,72970.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 29.86% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.7%
National Development Fund, Executive Yuan
30,098,439NT$656.1m0%0.04%
1.31%
Taiwan Huamao Investment Co., Ltd.
1,475,126NT$32.2m0%no data
0.63%
Dimensional Fund Advisors LP
706,069NT$15.4m0%no data
0.45%
Lian Sheng Investment Corportaion
509,878NT$11.1m0%no data
0.42%
Berkeley Capital Securities, LLC, Asset Management Arm
471,786NT$10.3m0%0.14%
0.2%
Zheng Chen
229,806NT$5.0m0%no data
0.1%
Cindy Chu
112,706NT$2.5m0%no data
0.027%
Hui Ling Lin
30,614NT$667.3k0%no data